Integrated Wealth Management (Palm Desert)’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
$1.87M Buy
28,692
+329
+1% +$20.7K 0.63% 42
2016
Q4
$1.78M Sell
28,363
-254
-0.9% -$15.5K 0.66% 43
2016
Q3
$1.8M Sell
28,617
-53
-0.2% -$3.43K 0.65% 43
2016
Q2
$1.77M Buy
28,670
+276
+1% +$16.8K 0.69% 34
2016
Q1
$1.62M Sell
28,394
-277
-1% -$15.4K 0.68% 35
2015
Q4
$1.7M Sell
28,671
-977
-3% -$56.3K 0.73% 31
2015
Q3
$1.61M Sell
29,648
-1,069
-3% -$69.6K 0.71% 32
2015
Q2
$2.06M Buy
30,717
+55
+0.2% +$3.59K 0.8% 26
2015
Q1
$1.79M Buy
+30,662
New +$1.85M 0.75% 26

Other funds holding ABBV

Integrated Wealth Management (Palm Desert)'s ABBV Position: Q1 2017 in Review

Integrated Wealth Management (Palm Desert) increased its AbbVie (ABBV) stake by 1.2% in Q1 2017, buying an estimated $20.7K and bringing the position to 28,692 shares worth $1.87M. The position accounts for 0.63% of the portfolio, ranked #42.

Integrated Wealth Management (Palm Desert) first reported a position in ABBV in Q1 2015 and has held it in 9 quarters since. The position peaked at $2.06M in Q2 2015. 1,727 funds tracked by Wall St. Rank hold ABBV as of Q1 2017.

  • Integrated Wealth Management (Palm Desert) held 28,692 shares of AbbVie worth $1.87M as of Q1 2017.
  • Integrated Wealth Management (Palm Desert) bought 329 AbbVie shares in Q1 2017, an estimated $20.7K.
  • AbbVie made up 0.63% of Integrated Wealth Management (Palm Desert)'s portfolio in Q1 2017, its #42 holding.
  • Integrated Wealth Management (Palm Desert) first reported a position in AbbVie in Q1 2015 and has held it in 9 quarters since.
  • Integrated Wealth Management (Palm Desert)'s AbbVie position peaked at $2.06M in Q2 2015.
  • 1,727 funds tracked by Wall St. Rank held AbbVie as of Q1 2017.

Based on Integrated Wealth Management (Palm Desert)'s 13F filing for Q1 2017, filed 14 Apr 2017.